Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2728482075;82076;82077 chr2:178564282;178564281;178564280chr2:179429009;179429008;179429007
N2AB2564377152;77153;77154 chr2:178564282;178564281;178564280chr2:179429009;179429008;179429007
N2A2471674371;74372;74373 chr2:178564282;178564281;178564280chr2:179429009;179429008;179429007
N2B1821954880;54881;54882 chr2:178564282;178564281;178564280chr2:179429009;179429008;179429007
Novex-11834455255;55256;55257 chr2:178564282;178564281;178564280chr2:179429009;179429008;179429007
Novex-21841155456;55457;55458 chr2:178564282;178564281;178564280chr2:179429009;179429008;179429007
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Ig-140
  • Domain position: 7
  • Structural Position: 11
  • Q(SASA): 0.3013
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs746222222 0.011 0.201 N 0.488 0.065 0.296679040009 gnomAD-3.1.2 1.97E-05 None None None None N None 0 0 0 0 0 None 0 0 4.41E-05 0 0
V/I rs746222222 0.011 0.201 N 0.488 0.065 0.296679040009 gnomAD-4.0.0 1.92153E-05 None None None None N None 0 0 None 0 2.22955E-05 None 0 0 2.37334E-05 0 3.20246E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.1452 likely_benign 0.1331 benign -0.841 Destabilizing 0.007 N 0.175 neutral N 0.449954505 None None N
V/C 0.5959 likely_pathogenic 0.6182 pathogenic -0.809 Destabilizing 0.992 D 0.517 neutral None None None None N
V/D 0.3091 likely_benign 0.2948 benign -0.351 Destabilizing 0.896 D 0.585 neutral N 0.443081674 None None N
V/E 0.2724 likely_benign 0.261 benign -0.431 Destabilizing 0.92 D 0.537 neutral None None None None N
V/F 0.1762 likely_benign 0.1712 benign -0.843 Destabilizing 0.681 D 0.523 neutral N 0.460185111 None None N
V/G 0.1869 likely_benign 0.1801 benign -1.036 Destabilizing 0.549 D 0.533 neutral N 0.459574066 None None N
V/H 0.5085 ambiguous 0.5119 ambiguous -0.552 Destabilizing 0.992 D 0.583 neutral None None None None N
V/I 0.0729 likely_benign 0.0708 benign -0.456 Destabilizing 0.201 N 0.488 neutral N 0.487107384 None None N
V/K 0.319 likely_benign 0.3324 benign -0.716 Destabilizing 0.766 D 0.539 neutral None None None None N
V/L 0.1483 likely_benign 0.1674 benign -0.456 Destabilizing 0.002 N 0.18 neutral N 0.481912208 None None N
V/M 0.1041 likely_benign 0.0988 benign -0.446 Destabilizing 0.85 D 0.503 neutral None None None None N
V/N 0.1937 likely_benign 0.1786 benign -0.475 Destabilizing 0.92 D 0.58 neutral None None None None N
V/P 0.6519 likely_pathogenic 0.661 pathogenic -0.548 Destabilizing 0.92 D 0.545 neutral None None None None N
V/Q 0.3075 likely_benign 0.3075 benign -0.687 Destabilizing 0.972 D 0.541 neutral None None None None N
V/R 0.3084 likely_benign 0.3242 benign -0.2 Destabilizing 0.92 D 0.58 neutral None None None None N
V/S 0.167 likely_benign 0.1523 benign -0.931 Destabilizing 0.447 N 0.515 neutral None None None None N
V/T 0.1178 likely_benign 0.1002 benign -0.902 Destabilizing 0.021 N 0.223 neutral None None None None N
V/W 0.762 likely_pathogenic 0.7874 pathogenic -0.922 Destabilizing 0.992 D 0.613 neutral None None None None N
V/Y 0.4406 ambiguous 0.477 ambiguous -0.639 Destabilizing 0.92 D 0.513 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.